Nektar Therapeutics
NKTR· Nasdaq
Released Aug 8, 2018, after the close
10-Q filed Aug 9, 2018, 40 days after period end · 0001564590-18-020709
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $1.09B | $34.59M | $32.77M | $22.66M |
| Net Income | $971.46M | -$59.87M | -$48.60M | -$52.66M |
| EPS Diluted | $5.33 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.36 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.